Dramatic rise in high blood pressure contributes to many U.S. deaths
the ONA take:
Deaths related to high blood pressure have sharply risen over the last 13 years, according to recent data from the CDC’s National Center for Health Statistics.
In the CDC’s report, hypertension-related deaths was found to have increased by 61.8 percent from 2000 to 2013, and the rate of incidence rose for both sexes aged 45 or older.
The researchers, who pulled their data from national cause-of-death files, counted any mention of hypertension on death certificates as a hypertension-related death.
Overall, one out of six hypertension-related deaths was due to high blood pressure as the underlying cause.
However, the report also found that the proportion of deaths where heart disease was the underlying cause of death had dropped by about 6 percent, while those with stroke as an underlying cause dropped by about 5 percent. High blood pressure was still a contributing factor to other deaths.
Deaths as a result of heart disease, stroke, cancer, and diabetes that mentioned hypertension in certificates made up 65 percent of counted deaths in 2000, and 54 percent of those in 2013.
Deaths related to high blood pressure have sharply risen over the last 13 years.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|